Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients.
Ann Marie NavarAhmed A KolkailahAnand GuptaKristin Khalaf GillardMarc K IsraelYiqing WangEric D PetersonPublished in: Circulation. Cardiovascular quality and outcomes (2023)
Among patients with ASCVD in routine care, high-intensity statins are underutilized, and uptitration and use of nonstatin therapy are uncommon. Women, older adults, and individuals with noncardiac ASCVD are particularly undertreated. Concerted efforts are needed to address therapeutic inertia for lipid management in patients with ASCVD.
Keyphrases
- high intensity
- end stage renal disease
- newly diagnosed
- healthcare
- ejection fraction
- resistance training
- quality improvement
- cardiovascular disease
- prognostic factors
- fatty acid
- palliative care
- type diabetes
- stem cells
- bone marrow
- chronic pain
- clinical practice
- metabolic syndrome
- mesenchymal stem cells
- body composition
- insulin resistance